Menu
GeneBe

NUMA1

nuclear mitotic apparatus protein 1, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 11:72002863-72080693

Links

ENSG00000137497NCBI:4926OMIM:164009HGNC:8059Uniprot:Q14980AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NUMA1 gene.

  • Inborn genetic diseases (88 variants)
  • not provided (27 variants)
  • Autosomal recessive nonsyndromic hearing loss 63 (8 variants)
  • Acute promyelocytic leukemia (2 variants)
  • NUMA1-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUMA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
3
clinvar
8
missense
88
clinvar
8
clinvar
10
clinvar
106
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
2
non coding
6
clinvar
1
clinvar
7
Total 0 0 94 14 13

Variants in NUMA1

This is a list of pathogenic ClinVar variants found in the NUMA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-72003944-G-A NUMA1-related disorder Likely benign (Apr 04, 2019)3052529
11-72003967-G-A not specified Uncertain significance (Mar 14, 2023)2456727
11-72003981-C-T not specified Uncertain significance (May 18, 2023)2548794
11-72004029-C-T not specified Uncertain significance (Sep 27, 2022)2313597
11-72004092-C-T not specified Uncertain significance (Jul 14, 2021)3202915
11-72004093-G-A not specified Uncertain significance (Jan 10, 2023)2459964
11-72004647-G-A not specified Uncertain significance (Oct 06, 2021)2390331
11-72004680-C-T not specified Uncertain significance (May 01, 2022)2286890
11-72004687-G-A Likely benign (Aug 28, 2018)784216
11-72004706-G-T NUMA1-related disorder Likely benign (Mar 26, 2019)3047738
11-72004715-C-G not specified Uncertain significance (Jul 06, 2021)2374386
11-72004750-G-A not specified Uncertain significance (Jun 30, 2022)2377178
11-72005249-T-C not specified Uncertain significance (Apr 07, 2022)2281562
11-72005307-G-A not specified Uncertain significance (Mar 28, 2023)2530409
11-72005334-C-T not specified Uncertain significance (Dec 21, 2022)2338205
11-72006045-C-T Likely benign (May 22, 2018)745147
11-72006063-C-G not specified Uncertain significance (Oct 25, 2022)2209191
11-72006074-G-A not specified Uncertain significance (Nov 10, 2022)2340565
11-72006137-C-T not specified Uncertain significance (Aug 11, 2021)2238805
11-72006217-C-G not specified Uncertain significance (Mar 29, 2023)2531221
11-72006221-A-G Likely benign (Apr 01, 2023)774210
11-72006247-T-A not specified Uncertain significance (Nov 03, 2023)3202913
11-72006254-C-T NUMA1-related disorder Benign (Jul 30, 2019)785365
11-72006255-A-T not specified Uncertain significance (Oct 12, 2021)2356361
11-72007223-C-T not specified Uncertain significance (Jun 22, 2023)2597967

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NUMA1protein_codingprotein_codingENST00000393695 2577830
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.25e-71257160321257480.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.88111191.21e+30.9290.000078513647
Missense in Polyphen396457.560.865465283
Synonymous0.1414814850.9920.00002674279
Loss of Function8.21151060.1410.000005711142

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002620.000262
Ashkenazi Jewish0.000.00
East Asian0.0002180.000217
Finnish0.0001400.000139
European (Non-Finnish)0.0001150.000114
Middle Eastern0.0002180.000217
South Asian0.00006540.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Microtubule (MT)-binding protein that plays a role in the formation and maintenance of the spindle poles and the alignement and the segregation of chromosomes during mitotic cell division (PubMed:7769006, PubMed:17172455, PubMed:19255246, PubMed:24996901, PubMed:26195665, PubMed:27462074). Functions to tether the minus ends of MTs at the spindle poles, which is critical for the establishment and maintenance of the spindle poles (PubMed:12445386, PubMed:11956313). Plays a role in the establishment of the mitotic spindle orientation during metaphase and elongation during anaphase in a dynein-dynactin-dependent manner (PubMed:23870127, PubMed:24109598, PubMed:24996901, PubMed:26765568). In metaphase, part of a ternary complex composed of GPSM2 and G(i) alpha proteins, that regulates the recruitment and anchorage of the dynein-dynactin complex in the mitotic cell cortex regions situated above the two spindle poles, and hence regulates the correct oritentation of the mitotic spindle (PubMed:23027904, PubMed:22327364, PubMed:23921553). During anaphase, mediates the recruitment and accumulation of the dynein- dynactin complex at the cell membrane of the polar cortical region through direct association with phosphatidylinositol 4,5- bisphosphate (PI(4,5)P2), and hence participates in the regulation of the spindle elongation and chromosome segregation (PubMed:22327364, PubMed:23921553, PubMed:24996901, PubMed:24371089). Binds also to other polyanionic phosphoinositides, such as phosphatidylinositol 3-phosphate (PIP), lysophosphatidic acid (LPA) and phosphatidylinositol triphosphate (PIP3), in vitro (PubMed:24996901, PubMed:24371089). Also required for proper orientation of the mitotic spindle during asymmetric cell divisions (PubMed:21816348). Plays a role in mitotic MT aster assembly (PubMed:11163243, PubMed:11229403, PubMed:12445386). Involved in anastral spindle assembly (PubMed:25657325). Positively regulates TNKS protein localization to spindle poles in mitosis (PubMed:16076287). Highly abundant component of the nuclear matrix where it may serve a non-mitotic structural role, occupies the majority of the nuclear volume (PubMed:10075938). Required for epidermal differentiation and hair follicle morphogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006, ECO:0000305|PubMed:10075938, ECO:0000305|PubMed:21816348}.;
Pathway
Ectoderm Differentiation;role of ran in mitotic spindle regulation;hiv-1 nef: negative effector of fas and tnf;Mitotic Prophase;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Caspase Cascade in Apoptosis (Consensus)

Recessive Scores

pRec
0.254

Intolerance Scores

loftool
0.402
rvis_EVS
-0.55
rvis_percentile_EVS
19.97

Haploinsufficiency Scores

pHI
0.0873
hipred
Y
hipred_score
0.520
ghis
0.573

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.667

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Numa1
Phenotype
cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
numa1
Affected structure
establishment of spindle orientation
Phenotype tag
abnormal
Phenotype quality
process quality

Gene ontology

Biological process
establishment of mitotic spindle orientation;microtubule bundle formation;nucleus organization;chromosome segregation;positive regulation of BMP signaling pathway;astral microtubule organization;positive regulation of microtubule polymerization;positive regulation of intracellular transport;positive regulation of keratinocyte differentiation;cell division;meiotic cell cycle;positive regulation of hair follicle development;positive regulation of chromosome segregation;anastral spindle assembly;regulation of mitotic spindle organization;regulation of metaphase plate congression;positive regulation of protein localization to spindle pole body;positive regulation of mitotic spindle elongation;positive regulation of protein localization to cell cortex;positive regulation of chromosome separation;positive regulation of spindle assembly
Cellular component
Golgi membrane;spindle pole;nucleus;nucleoplasm;chromosome;cytoplasm;centrosome;spindle;cytosol;spindle microtubule;cell cortex;lateral plasma membrane;nuclear matrix;extrinsic component of plasma membrane;dendrite;spindle pole centrosome;protein-containing complex;microtubule plus-end;microtubule minus-end;neuronal cell body;cortical microtubule;mitotic spindle astral microtubule;extracellular exosome;mitotic spindle;microtubule bundle;mitotic spindle pole;lateral cell cortex;cell cortex region;cytoplasmic microtubule bundle;mitotic spindle midzone
Molecular function
structural molecule activity;protein binding;microtubule binding;protein C-terminus binding;tubulin binding;protein domain specific binding;phosphatidylinositol binding;protein-containing complex binding;microtubule plus-end binding;microtubule minus-end binding;dynein complex binding;disordered domain specific binding